NIH Reporter #3R01CA286069-03S1

Using gene expression to identify patients at high risk for late breast cancer recurrence

The award funds a project to develop a gene expression profile to identify ER-positive breast cancer patients at high risk for late recurrence, facilitating targeted preventive treatment.

Description

This project aims to discover the first molecular test to predict a woman’s risk for late breast cancer recurrence. The study will develop a gene expression profile from primary breast tumors to stratify ER-positive breast cancer patients by their risk of late recurrence, enabling targeted prophylactic therapy.

View original record